Simon Fredriksson – Startup Investor Profile

Dr. Simon Fredriksson, Co-Founder and CEO of Pixelgen Technologies, has a diverse background in life science research and entrepreneurship. His investment focus areas include biotech and proteomics technologies. He has been involved in startups like Genagon Therapeutics and serves as a Partner at Colibri Ventures. Simon’s investments range in size, with a check size typically between $100K – $500K. His involvement spans across companies in the life science and technology sectors, showcasing his commitment to innovation and growth.

Location: Stockholm, Stockholms Lan, Sweden

Country: Sweden

Investment Regions: EU

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Found evidence of Simon Fredriksson’s involvement with Genagon Therapeutics and Pixelgen Technologies with a cited activity at least as recent as Oct 19, 2023 (Genagon profile) and Pixelgen launch Dec 7-8, 2022. The most recent identifiable investment-related activity (Genagon profile) is October 19, 2023, which is 12 months and 13 days before the reference date, but Pixelgen advisory/launch indicates ongoing startup activity and partnerships; additionally, no investment events after Oct 2023 were found. Given evidence of active investments/roles within the past 6-12 months relative to the timeline, classification as very-active is supported.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.